Exosomal PD-L1 has been increasingly considered a noninvasive and accurate predictive
marker for immunotherapy treatment response. However, the clinical monitoring of exosomal …

Exosomes have become the most ideal analysis target for liquid biopsy since they carry a
large amount of genetic materials. The study on exosomes has great significance for cancer …

Exosomes, a growing focus for liquid biopsies, contain diverse molecular cargos. In
particular, exosome metabolites with valuable information have exhibited great potential for …

Functional materials with good biocompatibility have been widely used in the study of
genomics, proteomics and disease diagnosis, which has improved the progress of life …

Circling exosomal PD-L1 can be expected as a predictor for the clinical responds of anti-PD-
1/PD-L1 therapy. Here, we present a simple method integrating capture and analysis of …

Programmed death ligand 1 (PD-L1) exosomes are important biomarkers of immune
activation in the initial stages of treatment and can predict clinical responses to PD-1 …

Biosensors developed through a sandwich approach have demonstrated favorable
detection performance for exosomal programmed cell death 1 ligand 1 (ExoPD-L1) …

Cancer released-exosomes containing specific surface proteins have high value in tumor
diagnosis and are considered a novel liquid biopsy biomarker. However, the development of …

Cancer-derived exosomes have recently emerged as potent candidates for diagnosis and
prognosis of breast cancer. As an example, programmed death ligand-1 positive (PD-L1+) …

Immunotherapy has reshaped the therapeutic landscape of many advanced tumors;
however, its effectiveness is seriously hampered due to the limitations of existing predictors …